SCHEMBL20103479

SCHEMBL20103479

O=C1N(c2ccccc2Cl)CCC12CCCCC2

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.51
HTR7 P34969 1/20 0.44
HTR1A P08908 5/20 0.43
ADRA1B P35368 5/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
CASP1 P29466 1/20 0.41
HSD17B10 Q99714 1/20 0.41
EGLN1 Q9GZT9 1/20 0.41
LIPE Q05469 1/20 0.41
ALOX5 P09917 2/20 0.41
ADRA1A P35348 2/20 0.40
LMNA P02545 1/20 0.39
NLRP3 Q96P20 1/20 0.39
ALB P02768 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18208689 0.84 HSD11B1 (0.51) HSD11B1ALDH1A1EGLN1LIPEALOX5
SCHEMBL20185049 0.84 HSD11B1 (0.51) HSD11B1HTR7ALDH1A1EGLN1LIPE
SCHEMBL549209 0.83 HSD11B1 (0.46) HSD11B1HTR7HTR1AADRA1BL3MBTL1
Hydrochloric Acid SCHEMBL2699664 0.82 HSD11B1 (0.45) HSD11B1HTR7ALDH1A1TSHREGLN1
Hydrochloric Acid SCHEMBL5568924 0.82 HSD11B1 (0.45) HSD11B1HTR7ALDH1A1TSHREGLN1
Hydrochloric Acid SCHEMBL550274 0.82 HSD11B1 (0.45) HSD11B1HTR7ALDH1A1TSHREGLN1
SCHEMBL12654777 0.81 KMT2A (0.50) HTR1AADRA1BEGLN1ADRA1A
Hydrochloric Acid SCHEMBL5568920 0.80 HSD11B1 (0.43) HSD11B1HTR7HTR1AADRA1BTSHR
SCHEMBL3700174 0.80 HSD11B1 (0.46) HSD11B1EGLN1ALB
SCHEMBL2703017 0.80 HSD11B1 (0.46) HSD11B1EGLN1ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018078005-A1 AMIDO-SUBSTITUTED AZASPIRO DERIVATIVES AS TANKYRASE INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed